Molecular Imaging in Oncology: Recent Advances

Dear Colleagues, 

Nuclear medicine and molecular imaging thrive under continuous change. Molecular imaging is a technique that facilitates the non-invasive imaging of molecular targets. As an imaging technique, PET has two unique characteristics: a very high sensitivity (at the picomolar level) and the possibility of visualizing and quantifying molecular processes and targets under investigation. Primarily, however, PET offers the opportunity to obtain pathophysiological information from living patients in a non-invasive and quantified way. In the current decade, a wave of new theranostic compounds, targeting the same receptor for imaging and therapy, will change the oncology therapeutic arsenal. The rapid development of quantitative molecular imaging (PET and SPECT), combined with high-level abilities in cross-sectional morphological imaging (CT and MRI), has excavated exciting opportunities. This way, the field of nuclear medicine has rejuvenated itself repeatedly. This Special Issue highlights the hot topics of the molecular imaging tracer principle, which provides rich soil for scientific discovery, clinical diagnosis, treatment response monitoring, image-guided decision making, precision medicine and personalized medicine, non-invasive tissue characterization, the development of new tracers and imaging biomarkers, the development of (radiomics-based) prediction tools, artificial intelligence, deep learning, Big Data, targeted radionuclide therapies, and personalized dosimetry.

Prof. Dr. Lioe-Fee de Geus-Oei
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.